| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5951132 | Atherosclerosis | 2009 | 6 Pages |
Abstract
Our data suggest that individual variability in RLP-C and HDL subpopulation response to HT is a predictor of CHD progression. Lipoprotein response to HT may be an indirect marker of susceptibility to other harmful effect of HT in postmenopausal women with established CHD or an indication of formation of dysfunctional lipoproteins.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Stefania Lamon-Fava, David M. Herrington, David M. Reboussin, Michelle Sherman, Katalin Horvath, Ernst J. Schaefer, Bela F. Asztalos,